3 Magnificent Growth Stocks to Buy in March
You can find growth stocks in every sector. With healthcare making up nearly one-fifth of the U.S. economy, it's a great place to look.
Three Motley Fool contributors have identified what they think are magnificent growth stocks to buy in March -- and all of them are in the healthcare sector. Here's why they picked Eli Lilly (NYSE: LLY), (NASDAQ: MRNA), and Vertex Pharmaceuticals (NASDAQ: VRTX).
David Jagielski (Eli Lilly): One stock that could potentially usurp one of the tech stocks in the "Magnificent Seven" is Eli Lilly. The company's prospects are truly magnificent, thanks to a couple of promising glucagon-like peptide-1 (GLP-1) drugs in Mounjaro (for diabetes) and Zepbound (weight loss).
Source Fool.com
Moderna Inc. Aktie
124,24 €
8,59 %
Ausgeglichenes Verhältnis bei der Moderna Inc. Aktie mit 11 Buy- und 12 Sell-Einschätzungen.
Das Kursziel von 21 € für Moderna Inc. signalisiert bei einem aktuellen Kurs von 124.24 € eine mögliche Minderung von über 50%.
